ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Physiology. Regulatory Integrative and Comparative Physiology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpregu.00222.2010PMID 21178125PMCID PMC3075080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.

  2010cited by this paper
• Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension

  2010influential reference
• Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

  2010cited by this paper
• Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure.

  2010cited by this paper
• Astroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medulla.

  2010cited by this paper
• Diminazene Aceturate Is an ACE2 Activator and a Novel Antihypertensive Drug

  2010cited by this paper
• Developmental changes in AT1 and AT2 receptor-protein expression in rats

  2010cited by this paper
• A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

  2010cited by this paper
• Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2: Prevention of Angiotensin II–Dependent Hypertension

  2010cited by this paper
• Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells.

  2009cited by this paper
• Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

  2009cited by this paper
• Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone

  2009cited by this paper
• Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia.

  2009cited by this paper
• Functional interactions between 7TM receptors in the renin-angiotensin system--dimerization or crosstalk?

  2009cited by this paper
• Cerebroprotective action of angiotensin 1‐7 in a rat model of ischemic stroke

  2009cited by this paper
• Angiotensin‐(1–7) through AT2 receptors mediates tyrosine hydroxylase degradation via the ubiquitin–proteasome pathway

  2009cited by this paper
• Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

  2009cited by this paper
• Angiotensin II Type 1 Receptor–Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice

  2009influential reference
• Impairment of the angiotensin-converting enzyme 2–angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension

  2009cited by this paper
• Angiotensin‐converting enzyme 2 gene targeting studies in mice: mixed messages

  2008cited by this paper
• Novel Antihypertensive Agents Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2

  2008cited by this paper
• Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

  2008cited by this paper
• An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy.

  2008cited by this paper
• Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation

  2008cited by this paper
• Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression

  2008cited by this paper
• Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice

  2008cited by this paper
• Injections of angiotensin‐converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats

  2008cited by this paper
• Brain angiotensin‐converting enzymes: role of angiotensin‐converting enzyme 2 in processing angiotensin II in mice

  2008cited by this paper
• Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats.

  2008cited by this paper
• Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction.

  2008cited by this paper
• Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression

  2008cited by this paper
• The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.

  2008cited by this paper
• Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats.

  2008cited by this paper
• Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents

  2008cited by this paper
• Angiotensin‐converting enzyme 2 in the brain: properties and future directions

  2008influential reference
• Effects of Angiotensin Type 2 Receptor Overexpression in the Rostral Ventrolateral Medulla on Blood Pressure and Urine Excretion in Normal Rats

  2008cited by this paper
• Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice

  2008cited by this paper
• Hemodynamic effect produced by microinjection of angiotensins at the caudal ventrolateral medulla of spontaneously hypertensive rats.

  2008cited by this paper
• Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function

  2008cited by this paper
• The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets

  2008cited by this paper
• MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.

  2008cited by this paper
• Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.

  2007cited by this paper
• Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.

  2007influential reference
• Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

  2007cited by this paper
• Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain.

  2007cited by this paper
• Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats

  2007cited by this paper
• Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla.

  2007influential reference
• Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991.

  2007cited by this paper
• Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways

  2007cited by this paper
• Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function

  2007cited by this paper
• ACE2: a new target for cardiovascular disease therapeutics.

  2007cited by this paper
• The Angiotensin-(1-7) Receptor Agonist AVE0991 Dominates the Circadian Rhythm and Baroreflex in Spontaneously Hypertensive Rats

  2007cited by this paper
• Enzymatic pathways of the brain renin–angiotensin system: Unsolved problems and continuing challenges

  2007influential reference
• The circumventricular organs: an atlas of comparative anatomy and vascularization.

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload–Induced Cardiac Dysfunction by Increasing Local Angiotensin II

  2006cited by this paper
• Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.

  2006cited by this paper
• Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.

  2006cited by this paper
• Evidence Supporting a Functional Role for Intracellular Renin in the Brain

  2006cited by this paper
• Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

  2006cited by this paper
• Physiology of local renin-angiotensin systems.

  2006cited by this paper
• Amino acids modulate the hypotensive effect of angiotensin-(1-7) at the caudal ventrolateral medulla in rats.

  2005cited by this paper
• In vivo characterization of the angiotensin‐(1–7)‐induced dopamine and γ‐aminobutyric acid release in the striatum of the rat

  2005cited by this paper
• Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone.

  2005influential reference
• Angiotensin-(1-7): blood, heart, and blood vessels.

  2005cited by this paper
• Short-Term Angiotensin(1-7) Receptor Mas Stimulation Improves Endothelial Function in Normotensive Rats

  2005cited by this paper
• The Endothelium-Dependent Vasodilator Effect of the Nonpeptide Ang(1-7) Mimic AVE 0991 Is Abolished in the Aorta of Mas-Knockout Mice

  2005cited by this paper
• Folic Acid Improves Baroreceptor Sensitivity in Hypertension

  2005cited by this paper
• Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function

  2005cited by this paper
• Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.

  2005cited by this paper
• Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.

  2004cited by this paper
• ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis

  2004cited by this paper
• Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

  2004cited by this paper
• Angiotensin-(1–7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats

  2004cited by this paper
• Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.

  2004influential reference
• Hypertension Caused by Angiotensin II Infusion Involves Increased Superoxide Production in the Central Nervous System

  2004cited by this paper
• Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.

  2004cited by this paper
• Membrane-associated zinc peptidase families: comparing ACE and ACE2

  2004cited by this paper
• Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor

  2004cited by this paper
• Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney

  2004cited by this paper
• Angiotensin-(1–7) Reduces Renal Angiotensin II Receptors through a Cyclooxygenase-Dependent Mechanism

  2003cited by this paper
• Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.

  2003cited by this paper
• Characterization of a New Selective Antagonist for Angiotensin-(1–7), d-Pro7-Angiotensin-(1–7)

  2003cited by this paper
• Brain renin–angiotensin system dysfunction in hypertension: recent advances and perspectives

  2003cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2*

  2003cited by this paper
• Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System

  2002cited by this paper
• Hypotensive effect of ANG II and ANG-(1-7) at the caudal ventrolateral medulla involves different mechanisms.

  2002cited by this paper
• Cellular targets for angiotensin II fragments: pharmacological and molecular evidence

  2002cited by this paper
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002cited by this paper
• AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

  2002cited by this paper
• Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.

  2002cited by this paper
• Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells

  2001cited by this paper
• Neuro-cardiovascular regulation from molecules to man

  2001cited by this paper
• The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.

  2001cited by this paper
• Angiotensin-(1-7)–Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells

  2001influential reference
• Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade

  2001cited by this paper
• Long-Lasting Cardiovascular Effects of Liposome-Entrapped Angiotensin-(1-7) at the Rostral Ventrolateral Medulla

  2001cited by this paper
• Neuro-cardiovascular regulation: from molecules to man. Introduction.

  2001cited by this paper

• Microglial Activation and RAS Signaling: A Dual-Edged Sword in Neuroinflammation.

  2026cites this paper
• Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington’s disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling

  2025cites this paper
• GABA and GABAergic dysfunction in COVID-19: Piecing the puzzle with targeting immunity and several inflammatory pathways.

  2025cites this paper
• The brain–heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation

  2025cites this paper
• Mas Receptor as a Target for Neuropathic Pain Management: Insights into Angiotensin-(1-7) Signaling and Therapeutic Opportunities

  2025cites this paper
• Synergistic Pathways in Parkinson's Disease: The Promise of FGF21 and ACE2.

  2025cites this paper
• Hematopoietic stem cell‑based angiotensin‑(1‑7) delivery to the brain improves functional outcomefollowing cerebral ischemia.

  2025cites this paper
• A perspective on small molecules targeting the renin-angiotensin-aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development.

  2025cites this paper
• Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats

  2025cites this paper
• Deep learning-driven proteomics analysis for gene annotation in the renin-angiotensin system

  2025cites this paper
• Peptide IRW upregulates ACE2 in spontaneously hypertensive rats via dopamine/D1R signaling pathway.

  2025cites this paper
• Serum Ang 1, Ang 1-7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome.

  2025cites this paper
• Oral Administration of Fermented Milk from Co-Starter Containing Lactobacillus plantarum Y44 Shows an Ameliorating Effect on Hypertension in Spontaneously Hypertensive Rats

  2024cites this paper
• SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

  2024cites this paper
• The 2023 Lewis K. Dahl Memorial Lecture: Angiotensin-Converting Enzyme 2 Posttranslational Modifications-Implications for Hypertension and SARS-CoV-2 Infection.

  2024cites this paper
• The relationship between morphological electrocardiographic characteristics and survival in critical COVID-19 patients

  2024cites this paper
• Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism

  2024cites this paper
• The Gift That Keeps on Giving

  2024cites this paper
• Diminazene aceturate poisoning in a dog (Canis familiaris) treated for visceral leishmaniasis: pathological and toxicological evaluation

  2024cites this paper
• Unraveling the role of the renin-angiotensin system in severe mental illnesses: An insight into psychopathology and cognitive deficits.

  2024cites this paper
• Activation of ACE2/Ang-(1–7)/Mas axis improves cognitive dysfunction induced by isoflurane in mice via inhibiting oxidative stress

  2024cites this paper
• ACE2 inhibits proliferation of smooth muscle cell through AT1R and its downstream signaling pathway

  2023cites this paper
• COVID-19 and Neurological Manifestations

  2023cites this paper
• Activation of Mas and pGCA receptor pathways protects renal epithelial cell damage against oxidative-stress-induced injury.

  2023cites this paper
• Cardiovascular dysfunction induced by combined exposure to nicotine inhalation and high fat diet.

  2023cites this paper
• Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension

  2023cites this paper
• Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?

  2023cites this paper
• Nedd4-2 upregulation is associated with ACE2 ubiquitination in hypertension.

  2023cites this paper
• MicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases

  2023cites this paper
• High frequency of endoluminal thrombus in patients with ischaemic stroke following AARS-CoV-2 infection.

  2023cites this paper
• The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury

  2023cites this paper
• Unusually Severe Bout in a Patient With a History of Cluster Headache Associated With COVID-19: A Case Report and Review of the Literature

  2023cites this paper
• Rational truncation, mutation, and halogenation of bradykinin neuropeptides as potent ACEII inhibitors by integrating molecular dynamics simulations, quantum mechanics calculations, and in vitro assays

  2022cites this paper
• Voluntary Exercise Prevents Hypertensive Response Sensitization Induced by Angiotensin II

  2022cites this paper
• ACE2 gene combined with exercise training attenuates central AngII/AT1 axis function and oxidative stress in a prehypertensive rat model.

  2022cites this paper
• AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment

  2022cites this paper
• Procalcitonin/Albumin Ratio as a Novel Biomarker for Predicting Mortality in COVID-19

  2022cites this paper
• International controlled study of revascularization and outcomes following COVID‐positive mechanical thrombectomy

  2022cites this paper
• Sensitization of Hypertension: The Impact of Earlier Life Challenges: Excellence Award for Hypertension Research 2021

  2022cites this paper
• Pathogenesis: Hemodynamic Alterations

  2022cites this paper
• Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease

  2022cites this paper
• Trigeminal Neuralgia in a Couple: Case Report

  2022cites this paper
• Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release

  2022cites this paper
• Targeting Brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: past, present and future.

  2022cites this paper
• ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors

  2022cites this paper
• MLN-4760 Induces Oxidative Stress without Blood Pressure and Behavioural Alterations in SHRs: Roles of Nfe2l2 Gene, Nitric Oxide and Hydrogen Sulfide

  2022cites this paper
• Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study

  2022cites this paper
• Effects of angiotensin peptides on colonic motility in rats

  2022cites this paper
• Neuroinflammation and COVID-19 Ischemic Stroke Recovery—Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis and NLRP3 Inflammasome

  2022cites this paper
• Angiotensin II and Angiotensin Receptors 1 and 2—Multifunctional System in Cells Biology, What Do We Know?

  2021cites this paper
• The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations

  2021cites this paper
• Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?

  2021cites this paper
• Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore.

  2021cites this paper
• ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations

  2021cites this paper
• Alta frecuencia de trombo endoluminal en pacientes con ictus isquémico tras la infección por coronavirus 2019

  2021cites this paper
• The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy

  2021influential citation
• Angiotensin-(1–7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14/miR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer's Disease

  2021cites this paper
• Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development

  2021cites this paper
• Neuropathogenesis of SARS-CoV-2 Infection

  2021cites this paper
• Neuro-COVID-19: an insidious virus in action.

  2021cites this paper
• COVID-19 and Headache Disorders

  2021cites this paper
• Captopril and losartan attenuate behavioural sensitization in mice chronically exposed to toluene.

  2021cites this paper
• Superior mesenteric artery thrombosis and small bowel necrosis: An uncommon thromboembolic manifestation in COVID-19 pneumonia

  2021cites this paper
• MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY

  2021cites this paper
• Angiotensin-Converting Enzyme Type 2 as a Molecular Mediator for Infection of Cells with SARS-CoV and SARS-CoV-2 Viruses

  2021cites this paper
• Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration

  2021cites this paper
• Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.

  2021cites this paper
• Spontaneous intracranial hemorrhage presenting in a patient with vitamin K deficiency and COVID-19: illustrative case

  2021cites this paper
• Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms

  2021cites this paper
• Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome

  2021cites this paper
• Neurological Complications of COVID-19: Underlying Mechanisms and Management

  2021cites this paper
• Ang(1–7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents

  2021cites this paper
• Influence of Ang-(1-7) intervention on ACE2-Ang (1-7)-Mas pathway activity, hepatic glucose metabolism and insulin resistance in type-2 diabetic rats

  2021cites this paper
• Naringin Exhibits Mas Receptor–Mediated Neuroprotection Against Amyloid Beta–Induced Cognitive Deficits and Mitochondrial Toxicity in Rat Brain

  2021cites this paper
• Cardiomyopathy and multiple arterial thrombosis in a patient with severe tachyform atrial fibrillation after COVID-19

  2021cites this paper
• Dysregulation of ACE2 Expression and Function in Co-morbid Disease Conditions Possibly Contributes to COVID-19 Complication Severity.

  2020cites this paper
• Potential detrimental role of soluble ACE2 in severe COVID‐19 comorbid patients

  2020cites this paper
• Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2.

  2020cites this paper
• Marinoid J, a phenylglycoside from Avicennia marina fruit, ameliorates cognitive impairment in rat vascular dementia: a quantitative iTRAQ proteomic study

  2020cites this paper
• In Reply: Dismantling the Apocalypse Narrative: The Myth of the COVID-19 Stroke

  2020cites this paper
• Endocrine Significance of SARS-CoV-2’s Reliance on ACE2

  2020cites this paper
• The ACE2/Ang (1–7)/MasR axis as an emerging target for antihypertensive peptides

  2020cites this paper
• Complications and Pathophysiology of COVID-19 in the Nervous System

  2020cites this paper
• The Renin-Angiotensin System in Huntington’s Disease: Villain or Hero?

  2020cites this paper
• Letter: Thrombotic Neurovascular Disease in COVID-19 Patients

  2020cites this paper
• Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons

  2020cites this paper
• Covid-19 And Co-Infections: An Overview Of Ace2 Mediated Viral Entry Of Sars-Cov-2 And Multiorgan Failure In Covid-19

  2020cites this paper
• Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.

  2020cites this paper
• Alveolar early progenitors in the aged human lung have increased expression of ACE2 accompanied with genes involved in beta-amyloid clearance: Indication of SARS-CoV-2 also using soluble ACE2 in aged-lungs to enter ACE2-negative cells

  2020cites this paper
• Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities?

  2020cites this paper
• Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli

  2020cites this paper
• Interactions of the Brain Renin-Angiotensin-System (RAS) and Inflammation in the Sensitization of Hypertension

  2020cites this paper
• Novel Coronavirus Characteristic Cerebrovasculopathic Effects

  2020cites this paper
• Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke

  2020cites this paper
• Dysregulation of ACE2 Expression and Function in Co-morbid Disease Conditions Possibly Contributes to COVID-19 Complication Severity

  2020cites this paper
• Use of dual-flow bioreactor to develop a simplified model of nervous-cardiovascular systems crosstalk: A preliminary assessment

  2020cites this paper
• COVID-19 cytokine storm: The anger of inflammation

  2020cites this paper
• SARS-CoV-2, an Underestimated Pathogen of the Nervous System

  2020cites this paper
• Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019

  2020cites this paper
• Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.

  2020cites this paper